Log In
Print
BCIQ
Print
Print this Print this
 

oxycodone (Remoxy) (PF-00345439)

Also known as: PTI-821

  Manage Alerts
Collapse Summary General Information
Company Pain Therapeutics Inc.
DescriptionHigh viscosity capsule formulation of oxycodone
Molecular Target Mu opioid receptor (OPRM1) (MOR) ; Kappa opioid receptor (OPRK1) (KOR)
Mechanism of ActionKappa opioid receptor agonist; Mu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsManage moderate to severe pain; Treat moderate to severe chronic pain; Treat moderate to severe osteoarthritic pain; Treat pain
Regulatory Designation

U.S. - Undisclosed Review (Treat moderate to severe chronic pain)

Partner

Durect Corp.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today